128 related articles for article (PubMed ID: 3286673)
1. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
[TBL] [Abstract][Full Text] [Related]
2. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
3. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
Paolisso G; Scheen AJ; Giugliano D; Sgambato S; Albert A; Varricchio M; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1991 Mar; 72(3):607-15. PubMed ID: 1997515
[TBL] [Abstract][Full Text] [Related]
5. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
[TBL] [Abstract][Full Text] [Related]
6. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
[TBL] [Abstract][Full Text] [Related]
7. Effects of pulsatile delivery of insulin and glucagon in humans.
Paolisso G; Scheen AJ; Albert A; Lefebvre PJ
Am J Physiol; 1989 Nov; 257(5 Pt 1):E686-96. PubMed ID: 2688437
[TBL] [Abstract][Full Text] [Related]
8. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
9. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
[TBL] [Abstract][Full Text] [Related]
12. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
13. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
Komjati M; Bratusch-Marrain P; Waldhäusl W
Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
[TBL] [Abstract][Full Text] [Related]
14. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
15. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline.
Attvall S; Fowelin J; von Schenck H; Smith U; Lager I
J Clin Endocrinol Metab; 1992 May; 74(5):1110-5. PubMed ID: 1569157
[TBL] [Abstract][Full Text] [Related]
16. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Østergård T; Degn KB; Gall MA; Carr RD; Veldhuis JD; Thomsen MK; Rizza RA; Schmitz O
J Clin Endocrinol Metab; 2004 Jan; 89(1):297-302. PubMed ID: 14715864
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
Asplin CM; Paquette TL; Palmer JP
J Clin Invest; 1981 Jul; 68(1):314-8. PubMed ID: 7019246
[TBL] [Abstract][Full Text] [Related]
19. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
Pal BR; Phillips PE; Matthews DR; Dunger DB
Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
[TBL] [Abstract][Full Text] [Related]
20. Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine.
Whittington KB; Solomon SS; Lu ZN; Selawry HP
Endocrinology; 1991 Jun; 128(6):2671-7. PubMed ID: 1674684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]